President and Chief Executive Officer

Arrowhead Pharmaceuticals Presents New Long-Term Efficacy...

Key facts: Beasley Allen Shared Talc Privilege; J&J Exited Arrowhead

Sarepta Pushes Past Gene Therapy Debacle as RNA Therapies Show Early Promise

Arrowhead (ARWR) FQ1 2026 Revenue Hits $264M as REDEMPLO Approval Marks Commercial Shift

Senior Writer, CMC Process Development

Arrowhead Pharmaceuticals is a commercial stage biopharmaceutical company focused on developing innovative drugs that treat intractable diseases through RNA interference. The Senior Writer will be responsible for preparing and maintaining technical documentation for process validation and other aspects of process development, emphasizing data review and report generation.

Co-Founder and Chief Operating Officer

City Therapeutics Pursues ‘Next Generation of RNAi’

Six RNAi companies to keep an eye on in 2026

City Therapeutics Announces Submission of Clinical Trial Application for CITY-FXI, an Investigational RNAi Therapeutic for the Treatment of Thromboembolic Diseases

0.800000011920929

Senior/Principal Scientist, CMC Process Development and Manufacturing

City Therapeutics is looking for a passionate Senior/Principal Scientist CMC Process Development and Manufacturing who will be responsible for leading drug substance process development projects for our programs at different stages. The role involves overseeing development projects, supporting non-GMP and GMP drug substance manufacturing, and collaborating with various cross-functional teams both internal and external.

Senior Writer, Cmc Process Development

Senior Writer, Cmc Process Development in united states (1000+)

Senior Writer, CMC Process Development

Senior/Principal Scientist, CMC Process Development and Manufacturing